Webinar
Summary:
Our host Dr Tom Fardon and his panel of experts will present a patient case study and discuss the most appropriate treatment options available.
With winter upon us, they will focus on a COPD patient at risk of exacerbations and discuss the following:
• Non-pharmacological interventions
• Treatment Optimisation
• So What? What outcomes can your patients expect?
The panel has a wide range of expertise covering both primary and secondary care. You can expect practical advice on how to treat this patient cohort.
Key Documents
Incruse ▼ Ellipta (umeclidinium bromide) Prescribing Information
Anoro ▼ Ellipta (umeclidinium/vilanterol) Prescribing Information
Trelegy ▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol) Prescribing Information
Relvar Ellipta (fluticasone furoate/vilanterol) Prescribing Information
Seretide (fluticasone propionate, salmeterol) Prescribing Information
Speakers
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on +44 (0)800 221 441
To complete your registration request please fill in the information below
Mandatory fields
Please fill in the information below to complete registration for this event
We will send you an email confirmation once your booking has been confirmed.